Research has identified a drug-resistant HSC-like stem cell subpopulation characterized by the CD69 surface marker in patients with leukemia, and has preliminarily revealed that CD69 mediates drug resistance by regulating the mTOR-CCND1-CXCR4 axis (95). The gene discussed is CD69; the disease is leukemia.